Details

Autor(en) / Beteiligte

• Eberhardt, W.E.E.
• De Ruysscher, D.
• Weder, W.
• Le Péchoux, C.
• De Leyn, P.
• Hoffmann, H.
• Westeel, V.
• Stahel, R.
• Felip, E.
• Peters, S.
• Stahel, Rolf
• Felip, Enriqueta
• Peters, Solange
• Kerr, Keith
• Besse, Benjamin
• Vansteenkiste, Johan
• Eberhardt, Wilfried
• Edelman, Martin
• Mok, Tony
• O'Byrne, Ken
• Novello, Silvia
• Bubendorf, Lukas
• Marchetti, Antonio
• Baas, Paul
• Reck, Martin
• Syrigos, Konstantinos
• Paz-Ares, Luis
• Smit, Egbert F.
• Meldgaard, Peter
• Adjei, Alex
• Nicolson, Marianne
• Crinó, Lucio
• Van Schil, Paul
• Senan, Suresh
• Faivre-Finn, Corinne
• Rocco, Gaetano
• Veronesi, Giulia
• Douillard, Jean-Yves
• Lim, Eric
• Dooms, Christophe
• Weder, Walter
• De Ruysscher, Dirk
• Le Pechoux, Cecile
• De Leyn, Paul
• Westeel, Virginie

Titel

2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer

Ist Teil von

• Annals of oncology, 2015-08, Vol.26 (8), p.1573-1588

Ort / Verlag

England: Elsevier Ltd

Erscheinungsjahr

2015

Quelle

MEDLINE

Beschreibungen/Notizen

• To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO Consensus Conference on Lung Cancer was held on 11–12 May 2013 in Lugano. A total of 35 experts met to address several questions on non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers, first-line/second and further lines of treatment in advanced disease, early-stage disease and locally advanced disease. For each question, recommendations were made including reference to the grade of recommendation and level of evidence. This consensus paper focuses on locally advanced disease.